Advanced search
Publication Cover
Expert Opinion on Biological Therapy Volume 10, 2010 - Issue 7
Submit an article Journal homepage
215
Views
17
CrossRef citations to date
0
Altmetric
Reviews

MUC1-based recombinant Bacillus Calmette–Guerin vaccines as candidates for breast cancer immunotherapy

Shifang Yuan Fourth Military Medical University, Xijing Hospital, Department of Vascular and Endocrine Surgery, Xi'an, 710032, People's Republic of China +86 2984773826; +86 2984773826; [email protected]
,
Changhong Shi Fourth Military Medical University, Laboratory Animal Research Center, 17 Changle West Road, Xi'an 710033, People's Republic of China
,
Li Liu Fourth Military Medical University, School of Pharmacy, Department of Pharmacology, Shaanxi, Xi'an 710032, People's Republic of China
&
Wei Han Fourth Military Medical University, Biotechnology Center, State Key Laboratory of Cancer Biology, 17 Changle West Road, Xi'an 710032, People's Republic of China
Pages 1037-1048 | Published online: 26 Apr 2010

Citations (17)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Nehad M Ayoub, Kamal M Al-Shami & Rami J Yaghan. (2019) Immunotherapy for HER2-positive breast cancer: recent advances and combination therapeutic approaches. Breast Cancer: Targets and Therapy 11, pages 53-69.
Read now

Articles from other publishers (16)

Narhari Gangaram Yedke, Shubham Upadhayay, Randhir Singh, Sumit Jamwal, Sheikh F. Ahmad & Puneet Kumar. (2023) Bacillus Calmette–Guérin Vaccine Attenuates Haloperidol-Induced TD-like Behavioral and Neurochemical Alteration in Experimental Rats. Biomolecules 13:11, pages 1667.
Crossref
Elaheh Tarighati, Hadi Keivan & Hojjat Mahani. (2022) A review of prognostic and predictive biomarkers in breast cancer. Clinical and Experimental Medicine.
Crossref
Martha Lucia Ruiz Benitez, Camila Bonnemann Bender, Thaís Larré Oliveira, Kyle M. Schachtschneider, Tiago Collares & Fabiana Kömmling Seixas. (2019) Mycobacterium bovis BCG in metastatic melanoma therapy. Applied Microbiology and Biotechnology 103:19, pages 7903-7916.
Crossref
Santhosh Rajendrakumar, Adityanarayan Mohapatra, Bijay Singh, Vishnu Revuri, Yong-Kyu Lee, Chang Kim, Chong-Su Cho & In-Kyu Park. (2018) Self-Assembled, Adjuvant/Antigen-Based Nanovaccine Mediates Anti-Tumor Immune Response against Melanoma Tumor. Polymers 10:10, pages 1063.
Crossref
Angeles C Tecalco-Cruz & Josué O Ramírez-Jarquín. (2018) Polyubiquitination inhibition of estrogen receptor alpha and its implications in breast cancer. World Journal of Clinical Oncology 9:4, pages 60-70.
Crossref
Ricardo D. Lardone, Alfred A. Chan, Agnes F. Lee, Leland J. Foshag, Mark B. Faries, Peter A. Sieling & Delphine J. Lee. (2017) Mycobacterium bovis Bacillus Calmette–Guérin Alters Melanoma Microenvironment Favoring Antitumor T Cell Responses and Improving M2 Macrophage Function. Frontiers in Immunology 8.
Crossref
Angeles C. Tecalco-Cruz & Josué O. Ramírez-Jarquín. (2017) Mechanisms that Increase Stability of Estrogen Receptor Alpha in Breast Cancer. Clinical Breast Cancer 17:1, pages 1-10.
Crossref
Md Hossain & Katherine Wall. (2016) Immunological Evaluation of Recent MUC1 Glycopeptide Cancer Vaccines. Vaccines 4:3, pages 25.
Crossref
Huixuan Li, Kai Chen, Fengxi Su, Erwei Song & Chang Gong. (2014) Preoperative CA 15-3 levels predict the prognosis of nonmetastatic luminal A breast cancer. Journal of Surgical Research 189:1, pages 48-56.
Crossref
Soumen Das, Retina Paul, Utpal De & Mrityunjay Mukherjee. (2013) Management of Breast Cancer by Vaccine: Fact or Fiction. Journal of the Islamic Medical Association of North America 44:1.
Crossref
Ursula Wiedermann, Adam B. Davis & Christoph C. Zielinski. (2013) Vaccination for the prevention and treatment of breast cancer with special focus on Her-2/neu peptide vaccines. Breast Cancer Research and Treatment 138:1, pages 1-12.
Crossref
Susan M. Love. 2013. Management of the Patient at High Risk for Breast Cancer. Management of the Patient at High Risk for Breast Cancer 169 184 .
Matteo Lazzeroni & Davide Serrano. (2012) Potential Use of Vaccines in the Primary Prevention of Breast Cancer in High-Risk Patients. Breast Care 7:4, pages 281-287.
Crossref
Silvia Park, Hee Kyung Ahn, Lee Chun Park, Deok Won Hwang, Jun Ho Ji, Chi Hoon Maeng, Su-Hee Cho, Ji Yean Lee, Kyung Tae Park, Jin Seok Ahn, Yeon Hee Park & Young-Hyuck Im. (2012) Implications of Different CA 15-3 Levels according to Breast Cancer Subtype at Initial Diagnosis of Recurrent or Metastatic Breast Cancer. Oncology 82:3, pages 180-187.
Crossref
Cristian Speil & Robert Rzepka. (2011) Vaccines and Vaccine Adjuvants as Biological Response Modifiers. Infectious Disease Clinics of North America 25:4, pages 755-772.
Crossref
Christine J Watson & Barry A Gusterson. (2010) A prophylactic vaccine for breast cancer?. Breast Cancer Research 12:4.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.